BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 23 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,502,311 | -20.1% | 702,234 | -3.6% | 0.64% | -15.6% |
Q2 2023 | $33,183,125 | +9.9% | 728,339 | -2.1% | 0.76% | +9.3% |
Q1 2023 | $30,181,142 | -9.2% | 744,111 | +14.1% | 0.70% | -8.3% |
Q4 2022 | $33,243,093 | -6.0% | 652,209 | -0.6% | 0.76% | -15.6% |
Q3 2022 | $35,348,000 | -4.3% | 656,297 | +14.1% | 0.90% | +5.7% |
Q2 2022 | $36,951,000 | +48.4% | 575,292 | +79.2% | 0.85% | +76.4% |
Q1 2022 | $24,894,000 | +37.2% | 321,046 | -41.9% | 0.48% | +49.4% |
Q3 2015 | $18,139,000 | -69.3% | 552,191 | -34.6% | 0.32% | -62.6% |
Q2 2015 | $59,030,000 | -2.4% | 844,136 | -4.4% | 0.87% | +1.6% |
Q1 2015 | $60,488,000 | -9.3% | 883,036 | -3.0% | 0.85% | -6.5% |
Q4 2014 | $66,719,000 | -2.3% | 910,341 | -4.3% | 0.91% | -1.3% |
Q3 2014 | $68,286,000 | -8.5% | 951,451 | -7.8% | 0.92% | +5.4% |
Q2 2014 | $74,623,000 | -4.3% | 1,032,136 | -2.6% | 0.88% | -6.3% |
Q1 2014 | $77,997,000 | +6.5% | 1,060,036 | +0.7% | 0.94% | +1.0% |
Q4 2013 | $73,240,000 | +30.9% | 1,053,056 | +23.6% | 0.93% | +21.5% |
Q3 2013 | $55,949,000 | -3.6% | 851,715 | +1.6% | 0.76% | -3.8% |
Q2 2013 | $58,049,000 | – | 838,006 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |